NCT06771791View on ClinicalTrials.gov

Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study

PHASE3RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

May 5, 2027

Study Completion Date

May 5, 2027

Conditions

Allergies

Interventions

OTHER

oral provocation test

Progressively increasing doses of peeled fresh Golden apple or placebo will be consumed by the patient (4g, 12g, 40g, 120g) with a time interval of 20 minutes between each dose.

Trial Locations (1)

67000

RECRUITING

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER